Synthesis of exotic polycycles such as cyclooctatrienes and fenestrenes with differential pro-apoptotic activities on human TRAIL-resistant metastatic cell lines

Bioorganic and Medicinal Chemistry Letters

Volumn 20, Issue 22, 2010, Pages 6836-6839

  Hulot, Catherine ^a   Peluso, Jean ^a   Blond, Gaëlle ^a   Muller, Christian D ^a   Suffert, Jean ^a  

^a UNIVERSITÉ DE STRASBOURG   (France)

Author keywords

Cyclooctatrienes; Electrocyclization; Fenestrenes; Pro apoptotic activities; Resistant metastatic cell SW620

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLOOCTATRIENE; FENESTRENE; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; COLON CARCINOMA; CYCLIZATION; DRUG ACTIVITY; DRUG MECHANISM; DRUG SYNTHESIS; HUMAN; HUMAN CELL; METASTASIS; MONOCYTIC LEUKEMIA; STRUCTURE ACTIVITY RELATION;

APOPTOSIS; CELL LINE, TUMOR; CRYSTALLOGRAPHY, X-RAY; HUMANS; POLYCYCLIC COMPOUNDS; TNF-RELATED APOPTOSIS-INDUCING LIGAND;

EID: 77958075137     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmcl.2010.08.094     Document Type: Article

References (25)

1. S.M. Kupchan, R.W. Britton, M.F. Ziegler, C.J. Gilmore, R.J. Restivo, and R.F. Bryan J. Am. Chem. Soc. 95 1973 1335
2. S. Nozoe, K. Hirai, and K. Tsuda Tetrahedron Lett. 7 1966 221
3. G. Mehta, and V. Singh Chem. Rev. 99 1999 881 930
4. N.A. Petasis, and M.A. Patane Tetrahedron 48 1992 5757
5. L. Yet Chem. Rev. 100 2000 2963
6. M. Gordaliza Clin. Trans. Oncol. 9 2007 767
7. M.C. Wani, H.L. Taylor, M.E. Wall, P. Coggon, and A.T. McPhail J. Am. Chem. Soc. 93 1971 2325
8. C. Hulot, S. Amiri, G. Blond, P. Schreiner, and J. Suffert J. Am. Chem. Soc. 131 2009 13387
9. C. Hulot, G. Blond, and J. Suffert J. Am. Chem. Soc. 130 2008 5046
10. R. Keese Chem. Rev. 106 2006 4787
11. M. Thommen, and R. Keese Synlett 1997 231
12. B.R. Venepalli, and W.C. Agosta Chem. Rev. 87 1987 399
13. D.B. Clarke, S.F.R. Hinkley, and R.T. Weavers Tetrahedron Lett. 38 1997 4297
14. R.E. Corbett, C.M. Couldwell, D.R. Lauren, and R.T. Weavers J. Chem. Soc., Perkin Trans. 1 1979 1791
15. S.H. Shim, J.B. Gloer, and D.T. Wicklow J. Nat. Prod. 69 2006 1601
16. S.H. Shim, D.C. Swenson, J.B. Gloer, P.F. Dowd, and D.T. Wicklow Org. Lett. 8 2006 1225
17. W.W. Lin, and M. Karin J. Clin. Invest. 117 2007 1175
18. M. Ozawa, T. Etoh, M. Hayashi, K. Komiyama, A. Kishida, and A. Ohsaki Bioorg. Med. Chem. Lett. 19 2009 234
19. C. Bour, and J. Suffert Eur. J. Org. Chem. 2006 1390
20. C.A. Brown, and V.K. Ahuja J. Chem. Soc., Chem. Commun. 1973 553
21. G.F. Pinna, M. Fiorucci, J.M. Reimund, N. Taquet, Y. Arondel, and C.D. Muller Biochem. Biophys. Res. Commun. 322 2004 778
22. G. Sethi, K.S. Ahn, M.K. Pandey, and B.B. Aggarwal Blood 109 2007 2727
23. A. Petronelli, G. Pannitteri, and U. Testa Anticancer Drugs 20 2009 880
24. Z. Jin, E.R. McDonald 3rd, D.T. Dicker, and W.S. El-Deiry J. Biol. Chem. 279 2004 35829
25. CCDC 707563 for 8a contains the supplementary crystallographic data for this paper. These data can be obtained free of charge via http://www.ccdc.cam. ac.uk/conts/retrieving.html (from the Cambridge Crystallographic Data Centre, 12, Union Road, Cambridge CB21EZ, UK; Tel.: +44 1223 336408; or deposit@ccdc.cam.ac.uk ).